Yuqian Yan

2.6k citations
37 papers · 1.4k indexed · h-index 19
Topics
Ubiquitin and proteasome pathways (9 papers)Prostate Cancer Treatment and Research (8 papers)Protein Degradation and Inhibitors (7 papers)

In The Last Decade

Yuqian Yan

37 papers receiving 1.3k citations

Peers

Yuqian Yan
Comparison fields: 5 of 78
  • Molecular Biology 1.0k
  • Oncology 392
  • Pulmonary and Respiratory Medicine 315
  • Cancer Research 278
  • Hematology 114
Replace Davide Pellacani with:
Davide Pellacani United Kingdom
Lesley Mathews United States
Teeru Bihani United States
Nicole E. Willmarth United States
Xiao-Feng Le United States
Ángel Guerrero‐Zotano Spain
Katharine Ellwood‐Yen United States
Gloria Manzotti Italy
Xiaofang Xing China
Wenwen Chien United States
Yuqian Yan relative to Davide Pellacani United Kingdom Davide Pellacani's profile →
Citations per field
00.5×5.5×
Davide Pellacani · 1×
Citations per year

Countries citing papers authored by Yuqian Yan

Since Specialization
Citations

This map shows the geographic impact of Yuqian Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuqian Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuqian Yan more than expected).

Fields of papers citing papers by Yuqian Yan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuqian Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuqian Yan. The network helps show where Yuqian Yan may publish in the future.

Co-authorship network of co-authors of Yuqian Yan

This figure shows the co-authorship network connecting the top 25 collaborators of Yuqian Yan. A scholar is included among the top collaborators of Yuqian Yan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuqian Yan. Yuqian Yan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 2
4 23
5 54
6 25
7 1
8 17
9 31
10 14
11 17
12 51
13 124
14 10
15 194
16 47
17 14
18 49
19 82
20 16

About Yuqian Yan

Yuqian Yan is a scholar working on Geriatrics and Gerontology, Pathology and Forensic Medicine and Molecular Biology, having authored 37 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Prostate Cancer Treatment and Research (8 papers) and Protein Degradation and Inhibitors (7 papers). The work is most often cited by research in Cancer Research (278 citations), Molecular Biology (1.0k citations) and Oncology (392 citations). Yuqian Yan has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Haojie Huang, Yunqian Pan, Donglin Ding, Xin Jin, Liguo Wang, Dejie Wang, Tao Ma, Rafael E. Jiménez, Heshui Wu and Robert G. Ramsay. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Molecular Cell.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026